TY - JOUR
T1 - The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): A living meta-analysis.
JO - Journal of Clinical Oncology
UR - http://dx.doi.org/10.1200/jco.2023.41.16_suppl.5088
PY - 2023/06/01
AU - Naqvi SAA
AU - Riaz IB
AU - He H
AU - Imran M
AU - Orme J
AU - Childs DS
AU - Ravi P
AU - Hussain SA
AU - Singh P
AU - Bryce AH
ED -
DO - DOI: 10.1200/jco.2023.41.16_suppl.5088
PB - American Society of Clinical Oncology (ASCO)
VL - 41
IS - 16_suppl
SP - 5088
EP - 5088
Y2 - 2025/01/07
ER -